Role of PET/CT scanning in initial and post-treatment assessment of Hodgkin disease.
The add-on value of F18-fluorodeoxyglucose PET, particularly when combined with CT, to the conventional workup in managing patients with Hodgkin disease has now been well documented. This article reviews the use of these imaging modalities in the initial staging and post-treatment assessment of Hodgkin disease.
Erturk
Sukru Mehmet
SM
Department of Radiology, Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
Van den Abbeele
Annick D
AD
D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D012008:Recurrence; D014055:Tomography, Emission-Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18